EPS Creative Health Technology Group First Half 2025 Earnings: EPS: HK$0.028 (vs HK$0.01 loss in 1H 2024)
EPS Creative Health Technology Group (HKG:3860) First Half 2025 Results
Key Financial Results
- Revenue: HK$346.9m (down 3.1% from 1H 2024).
- Net income: HK$14.7m (up from HK$5.24m loss in 1H 2024).
- Profit margin: 4.2% (up from net loss in 1H 2024).
- EPS: HK$0.028 (up from HK$0.01 loss in 1H 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
EPS Creative Health Technology Group shares are up 6.7% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 3 warning signs for EPS Creative Health Technology Group you should be aware of, and 1 of them is concerning.
Valuation is complex, but we're here to simplify it.
Discover if EPS Creative Health Technology Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:3860
EPS Creative Health Technology Group
An investment holding company, operates as an apparel supply chain management service provider in Hong Kong, Mainland China, Japan, the United States, Europe, and internationally.
Mediocre balance sheet low.